Gene · 10288
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Leukocyte immunoglobulin-like receptor B2 regulates atherosclerosis progression by modulating macrophage extracellular trap formation in foam macrophages through the PI3K-AKT signaling pathway. | J Cell Commun Signal | 2025 | 41235141 | PubTator, text mining | PubMed |
| The SPI1/LILRB2 axis modulates macrophage tolerance via crosstalk with TLR8 signaling: implications for sepsis immunotherapy. | Inflamm Res | 2025 | 41144021 | PubTator, text mining | PubMed |
| ILT-2 and ILT-4 expression and donor genotype as factors associated with HSCT outcome. | Clin Immunol | 2025 | 41046108 | PubTator, text mining | PubMed |
| Risk and Association of Specific HLA Alleles With Nintedanib-Induced Gastrointestinal Adverse Reactions: A Discovery Study in an Italian Population. | Clin Transl Sci | 2025 | 41017748 | PubTator, text mining | PubMed |
| Targeting ILT4 to Improve Immunotherapy Efficacy in Solid Tumour: From Bench to Bedside. | Immunotargets Ther | 2025 | 40989721 | PubTator, text mining | PubMed |
| C4d, a high-affinity LilrB2 ligand, is elevated in Alzheimer's disease and mediates synapse pruning. | Proc Natl Acad Sci U S A | 2025 | 40966293 | PubTator, text mining | PubMed |
| Distinct expression profiles of hsa-miR-31, hsa-miR-29c, hsa-miR-17, and hsa-miR-10a in oral epithelial dysplasia and squamous cell carcinoma. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2025 | 40957750 | PubTator, text mining | PubMed |
| Butterfly-like photo-responsive cyclometalated Ir(III) complex: emergence of a future cancer therapeutic agent. | Dalton Trans | 2025 | 40955583 | PubTator, text mining | PubMed |
| Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine. | Cancer Med | 2025 | 40948290 | PubTator, text mining | PubMed |
| Evaluating the causal effect of circulating proteome on the risk of Juvenile idiopathic arthritis: an omics pipeline study. | Pediatr Rheumatol Online J | 2025 | 40898345 | PubTator, text mining | PubMed |
| Identification of Therapeutic Targets for Premature Ovarian Failure Through Mendelian Randomization and Colocalization Analysis Using Human Plasma Proteomics. | J Mol Neurosci | 2025 | 40883588 | PubTator, text mining | PubMed |
| Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS. | Cells | 2025 | 40862727 | PubTator, text mining | PubMed |
| Two specific interactions of GATE16 with TRPML3 and RAB33B regulate autophagy. | Sci Rep | 2025 | 40855209 | PubTator, text mining | PubMed |
| Lipid homeostasis dysregulation in oral cancer drives metabolic reprogramming and offers novel diagnostic and therapeutic opportunities. | Discov Oncol | 2025 | 40853574 | PubTator, text mining | PubMed |
| Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. | Signal Transduct Target Ther | 2025 | 40850976 | PubTator, text mining | PubMed |
| Immunosenescence and cancer: molecular hallmarks, tumor microenvironment remodeling, and age-specific immunotherapy challenges. | J Hematol Oncol | 2025 | 40846970 | PubTator, text mining | PubMed |
| Comprehensive analysis of the leukocyte immunoglobulin-like receptor family in clear cell renal cell carcinoma. | Ann Med | 2025 | 40843931 | PubTator, text mining | PubMed |
| In depth characterisation of the proteome of MIS-C and post COVID-19 infection in children reveals inflammatory pathway activation and evidence of tissue damage. | J Transl Med | 2025 | 40826070 | PubTator, text mining | PubMed |
| Kawasaki disease: insights into the roles of T cells. | Front Immunol | 2025 | 40746545 | PubTator, text mining | PubMed |
| Global Protein-Ligand Binding Affinity Profiling via Photocatalytic Labeling. | bioRxiv | 2025 | 40631297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10288/papers?page=3